Recent trends in mortality due to chronic obstructive pulmonary disease (COPD) in Mexico, 1980-2002

被引:6
|
作者
Guzmán, VJT [1 ]
Antuñano, FJL [1 ]
Salgado, NR [1 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest & Salud Poblac, Dept Invest & Tabaco, Cuernavaca 62508, Morelos, Mexico
关键词
mortality; COPD; Mexico; epidemiology; trends;
D O I
10.1016/j.arcmed.2004.11.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not fully reversible. Changes in classification have a major impact on reported mortality rates. Methods. Between 1980 and 2002, 230,463 COPD cases were studied (age group 35-94 years); 134,579 men; 95,884 women. Results. The crude mortality rate varied from 37 (1980) to 61 per 100,000 men (2002), (increase: 65%). The crude mortality rate for females increased from 27 (1980) to 43 deaths per 100,000 women (2002), (increase: 56%). The trends of the absolute values by birth year and age groups are higher as age increases. As age of death comes down and the birth cohort increases, the absolute values decrease. The Mexican states located in the northern and central areas present a higher risk for dying. There is an increment coefficient of 93 cases per increment year in males (age group 35-74), and 61 cases per increment year in females (age group 35-74 years). For the age group 35-94 years, the annual increase for males is 288 cases. These results were statistically significant, and the regression model was validated by residual analysis. Conclusions. The oldest cohorts of the studied population showed the highest COPD mortality absolute values. The geographic risk of dying from COPD is concentrated in two regions: a) the three Mexican states of higher economic income at the northern frontier to the U.S. and b) those Mexican states surrounding the main producer of tobacco (Nayarit). (c) 2005 IMSS. Published by Elsevier Inc.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 50 条
  • [31] Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD)
    Hallin, Runa
    Gudmundsson, Gunnar
    Ulrik, Charlotte Suppli
    Nieminen, Markku M.
    Gislason, Thorarinn
    Lindberg, Eva
    Brondum, Eva
    Aine, Tiina
    Bakke, Per
    Janson, Christer
    RESPIRATORY MEDICINE, 2007, 101 (09) : 1954 - 1960
  • [32] Trends in Cause-Specific Mortality in Oxygen-dependent Chronic Obstructive Pulmonary Disease
    Ekstrom, Magnus P.
    Wagner, Philippe
    Strom, Kerstin E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (08) : 1032 - 1036
  • [33] Systemic inflammation and mortality in chronic obstructive pulmonary disease
    Sin, Don D.
    Man, S. F. Paul
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 85 (01) : 141 - 147
  • [34] Impact of pharmacological and non-pharmacological interventions on mortality in chronic obstructive pulmonary disease (COPD) patients
    Zysman, Maeva
    Mahay, Guillaume
    Guibert, Nicolas
    Barnig, Cindy
    Leroy, Sylvie
    Guilleminault, Laurent
    RESPIRATORY MEDICINE AND RESEARCH, 2023, 84
  • [35] Mortality prediction in chronic obstructive pulmonary disease and obstructive sleep apnea
    Bae, Eunhye
    Kwak, Nakwon
    Choi, Sun Mi
    Lee, Jinwoo
    Park, Young Sik
    Lee, Chang-Hoon
    Lee, Sang-Min
    Yoo, Chul-Gyu
    Cho, Jaeyoung
    SLEEP MEDICINE, 2021, 87 : 143 - 150
  • [36] Recent Evidences of Epigenetic Alterations in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review
    Ragusa, Rosetta
    Bufano, Pasquale
    Tognetti, Alessandro
    Laurino, Marco
    Caselli, Chiara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [37] Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation
    Cerezo Lajas, Alicia
    Liendo Martinez, Katiuska Herminia
    Suarez Escudero, Sergio
    Gallo Gonzalez, Virginia
    Puente Maestu, Luis
    Miguel Diez, Javier De
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [38] Effect of Smoking on Mortality in Individuals With Chronic Obstructive Pulmonary Disease (COPD) in the United States
    Adebile, Tolulope V.
    Asifat, Olamide A.
    Dey, Susmita
    Nwaonumah, Emmanuela C.
    Yu, Lili
    RESPIRATORY CARE, 2025,
  • [39] Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
    Valvi, Deepa
    Mannino, David M.
    Muellerov, Hana
    Tal-Singer, Ruth
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 173 - 182
  • [40] THE IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) COMORBIDITIES ON PROGNOSIS AND SEVERITY OF THE DISEASE
    Rysiak, Edyta
    Zareba, Ilona
    Prokop, Izabela
    Mroz, Robert
    ACTA POLONIAE PHARMACEUTICA, 2018, 75 (02): : 549 - 554